Spinnaker Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.3M | Sell |
11,221
-854
| -7% | -$866K | 0.57% | 42 |
|
|
2025
Q4 | $13M | Buy |
12,075
+83
| +0.7% | +$79.4K | 0.69% | 33 |
|
|
2025
Q3 | $9.15M | Sell |
11,992
-343
| -3% | -$255K | 0.51% | 45 |
|
|
2025
Q2 | $9.62M | Sell |
12,335
-2,735
| -18% | -$2.13M | 0.58% | 39 |
|
|
2025
Q1 | $12.4M | Sell |
15,070
-2,399
| -14% | -$2M | 0.81% | 26 |
|
|
2024
Q4 | $13.5M | Sell |
17,469
-386
| -2% | -$320K | 0.85% | 27 |
|
|
2024
Q3 | $15.8M | Sell |
17,855
-222
| -1% | -$200K | 0.97% | 21 |
|
|
2024
Q2 | $16.4M | Sell |
18,077
-1,800
| -9% | -$1.44M | 1.05% | 21 |
|
|
2024
Q1 | $15.5M | Sell |
19,877
-5,647
| -22% | -$4.02M | 1% | 21 |
|
|
2023
Q4 | $14.9M | Buy |
25,524
+16
| +0.1% | +$9.34K | 1.01% | 22 |
|
|
2023
Q3 | $13.7M | Sell |
25,508
-1,544
| -6% | -$796K | 1.03% | 21 |
|
|
2023
Q2 | $12.7M | Sell |
27,052
-3,717
| -12% | -$1.56M | 0.92% | 24 |
|
|
2023
Q1 | $10.6M | Buy |
30,769
+157
| +0.5% | +$53K | 0.8% | 27 |
|
|
2022
Q4 | $11.2M | Sell |
30,612
-1,052
| -3% | -$373K | 0.87% | 25 |
|
|
2022
Q3 | $10.2M | Buy |
31,664
+331
| +1% | +$105K | 0.85% | 25 |
|
|
2022
Q2 | $10.2M | Sell |
31,333
-2,614
| -8% | -$785K | 0.78% | 27 |
|
|
2022
Q1 | $9.72M | Buy |
33,947
+118
| +0.3% | +$30.4K | 0.66% | 31 |
|
|
2021
Q4 | $9.34M | Sell |
33,829
-2,722
| -7% | -$690K | 0.6% | 38 |
|
|
2021
Q3 | $8.45M | Buy |
36,551
+642
| +2% | +$158K | 0.59% | 37 |
|
|
2021
Q2 | $8.24M | Buy |
35,909
+720
| +2% | +$145K | 0.57% | 40 |
|
|
2021
Q1 | $6.57M | Buy |
35,189
+721
| +2% | +$141K | 0.49% | 49 |
|
|
2020
Q4 | $5.82M | Buy |
34,468
+27,723
| +411% | +$4.14M | 0.46% | 51 |
|
|
2020
Q3 | $998K | Hold |
6,745
| – | – | 0.09% | 115 |
|
|
2020
Q2 | $1.11M | Hold |
6,745
| – | – | 0.1% | 108 |
|
|
2020
Q1 | $935K | Hold |
6,745
| – | – | 0.1% | 116 |
|
|
2019
Q4 | $886K | Hold |
6,745
| – | – | 0.08% | 136 |
|
|
2019
Q3 | $754K | Hold |
6,745
| – | – | 0.07% | 140 |
|
|
2019
Q2 | $747K | Hold |
6,745
| – | – | 0.08% | 137 |
|
|
2019
Q1 | $875K | Buy |
6,745
+3,123
| +86% | +$380K | 0.09% | 127 |
|
|
2018
Q4 | $419K | Buy |
3,622
+167
| +5% | +$18.7K | 0.05% | 155 |
|
|
2018
Q3 | $370K | Buy |
3,455
+719
| +26% | +$71.9K | 0.04% | 174 |
|
|
2018
Q2 | $233K | Hold |
2,736
| – | – | 0.02% | 199 |
|
|
2018
Q1 | $211K | Hold |
2,736
| – | – | 0.02% | 206 |
|
|
2017
Q4 | $231K | Hold |
2,736
| – | – | 0.03% | 200 |
|
|
2017
Q3 | $234K | Hold |
2,736
| – | – | 0.03% | 189 |
|
|
2017
Q2 | $225K | Buy |
2,736
+46
| +2% | +$3.75K | 0.03% | 188 |
|
|
2017
Q1 | $226K | Buy |
+2,690
| New | +$215K | 0.03% | 188 |
|
|
2016
Q4 | – | Sell |
-2,690
| Closed | -$216K | – | 197 |
|
|
2016
Q3 | $216K | Hold |
2,690
| – | – | 0.03% | 178 |
|
|
2016
Q2 | $212K | Buy |
+2,690
| New | +$203K | 0.03% | 186 |
|
|
2016
Q1 | – | Sell |
-2,438
| Closed | -$205K | – | 206 |
|
|
2015
Q4 | $205K | Hold |
2,438
| – | – | 0.03% | 199 |
|
|
2015
Q3 | $204K | Sell |
2,438
-38
| -2% | -$3.21K | 0.03% | 193 |
|
|
2015
Q2 | $207K | Buy |
+2,476
| New | +$189K | 0.03% | 192 |
|
|
2014
Q2 | – | Sell |
-3,438
| Closed | -$202K | – | 171 |
|
|
2014
Q1 | $202K | Buy |
+3,438
| New | +$192K | 0.03% | 169 |
|
Other funds holding LLY
VCM
VPM
Spinnaker Trust's LLY Position: Q1 2026 in Review
Spinnaker Trust reduced its Eli Lilly (LLY) stake by 7.1% in Q1 2026, selling an estimated $866K and leaving 11,221 shares worth $10.3M. The position accounts for 0.57% of the portfolio, ranked #42.
Spinnaker Trust first reported a position in LLY in Q1 2014 and has held it in 43 quarters since. The position peaked at $16.4M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Spinnaker Trust held 11,221 shares of Eli Lilly worth $10.3M as of Q1 2026.
- Spinnaker Trust sold 854 Eli Lilly shares in Q1 2026, an estimated $866K.
- Eli Lilly made up 0.57% of Spinnaker Trust's portfolio in Q1 2026, its #42 holding.
- Spinnaker Trust first reported a position in Eli Lilly in Q1 2014 and has held it in 43 quarters since.
- Spinnaker Trust's Eli Lilly position peaked at $16.4M in Q2 2024.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Spinnaker Trust's 13F filing for Q1 2026, filed 23 Apr 2026.